BGI
BGI provides comprehensive health solutions across various regions in China, focusing on maternal and child health, infection prevention, cancer prevention, and chronic disease prevention. The company has also expanded its services internationally, establishing laboratories in Uzbekistan and Uruguay.
Services
BGI provides comprehensive solutions in the fields of maternal and child health, infection prevention, cancer prevention, and chronic disease prevention. Their services extend across various regions, each focusing on specific health priorities. They offer high-throughput gene detection solutions like PTseq™ for respiratory infections and have developed the HALOS system for tumor gene detection data analysis and interpretation. Additionally, BGI provides non-invasive prenatal gene testing, newborn genetic metabolic disease testing, and cervical cancer DNA methylation detection through their various products and laboratory services.
Regional Operations in China
BGI operates regionally across South, East, North, Central, Southwest, and Northwest China, addressing unique health concerns in each area. In the South, which includes Guangdong, Guangxi, Hainan, and Fujian, the focus is on thalassemia prevention. The East, covering Shanghai, Jiangsu, Zhejiang, Anhui, and Shandong, emphasizes research-driven clinical business. In the North, which includes Beijing and surrounding provinces, gene technology integration into major projects is a priority. The Central region covers Hunan, Hubei, Henan, and Jiangxi, focusing on expanding gene health screening projects. The Southwest, comprising Yunnan, Guizhou, Sichuan, and Chongqing, aims to create a comprehensive delivery center. In the Northwest, which includes Shaanxi, Gansu, and nearby provinces, BGI is building precision medicine centers.
International Presence
Beyond China, BGI has established a significant international presence. One notable example is the Genscreen laboratory in Tashkent, Uzbekistan, which provides non-invasive prenatal gene testing and newborn genetic metabolic disease testing services. Additionally, they have set up a clinical molecular detection laboratory in Uruguay to cater to the Latin American market. These international efforts demonstrate BGI's commitment to global health initiatives.
Innovative Products
BGI has rolled out several innovative products to advance global health. The PTseq™ respiratory infection pathogen targeted high-throughput gene detection solution is a notable example, as is their upgraded HALOS system for tumor gene detection data analysis. Another key product is the Huayankang cervical cancer DNA methylation detection solution, which aims to assist in eliminating cervical cancer through precise and efficient testing.
Industry Recognition
BGI has been recognized for its contributions to the health industry. The company has received the 'Shenzhen Famous Brand' and 'Bay Area Famous Brand' honors, showcasing their reputable status and the value of their services and products in public health.